Exelixis
EXEL
#1769
Rank
NZ$20.54 B
Marketcap
NZ$76.31
Share price
0.05%
Change (1 day)
20.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company